Lipitor

Lipitor is a brand name of atorvastatin, approved by the FDA in the following formulation(s):

LIPITOR (atorvastatin calcium - tablet; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: December 17, 1996
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 20MG BASE ^[AB], EQ 40MG BASE ^[AB]


• 
  Manufacturer: PFIZER
  
  Approval date: April 7, 2000
  
  Strength(s): EQ 80MG BASE ^[RLD][AB]

Has a generic version of Lipitor been approved?

A generic version of Lipitor has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Lipitor and have been approved by the FDA:

atorvastatin calcium tablet; oral

• 
  Manufacturer: RANBAXY LABS LTD
  
  Approval date: November 30, 2011
  
  Strength(s): EQ 10MG BASE ^[AB], EQ 20MG BASE ^[AB], EQ 40MG BASE ^[AB], EQ 80MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lipitor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Stable oral CI-981 formulation and process of preparing same
  Patent 5,686,104
  Issued: November 11, 1997
  Inventor(s): Mills; Nancy & Muhammad; Nouman A. & Weiss; Jay & Nesbitt; Russell U.
  Assignee(s): Warner-Lambert Company
  An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
  
  Patent expiration dates:
  
  
  • November 11, 2014
    
    ✓ 
    Patent use: METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA AND METHOD FOR TREATING HYPERLIPIDEMIA
    ✓ 
    Drug product
  
  
  
  • May 11, 2015
    
    ✓ 
    Patent use: METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA AND METHOD FOR TREATING HYPERLIPIDEMIA
    ✓ 
    Pediatric exclusivity
  
  



• 
  Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
  Patent 5,969,156
  Issued: October 19, 1999
  Inventor(s): Briggs; Christopher A. & Jennings; Rex A. & Wade; Robert & Harasawa; Kikuko & Ichikawa; Shigeru & Minohara; Kazuo & Nakagawa; Shinsuke
  Assignee(s): Warner-Lambert Company
  Crystalline forms of atorvastatin and hydrates thereof are useful hypolipidemic and hypocholesterolemic agents.
  
  Patent expiration dates:
  
  
  • July 8, 2016
    
    ✓ 
    Drug substance
  
  
  
  • January 8, 2017
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Stable oral CI-981 formulation and process for preparing same
  Patent 6,126,971
  Issued: October 3, 2000
  Inventor(s): Mills; Nancy & Muhammad; Nouman A. & Weiss; Jay & Nesbitt; Russell U.
  Assignee(s): Warner-Lambert Company
  An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
  
  Patent expiration dates:
  
  
  • January 19, 2013
    
    ✓ 
    Drug product
  
  
  
  • July 19, 2013
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Lipitor Consumer Information (Drugs.com)
• Lipitor Consumer Information (Wolters Kluwer)
• Lipitor Consumer Information (Cerner Multum)
• Lipitor Advanced Consumer Information (Micromedex)
• Lipitor AHFS DI Monographs (ASHP)
• Atorvastatin Consumer Information (Drugs.com)
• Atorvastatin Consumer Information (Wolters Kluwer)
• Atorvastatin Consumer Information (Cerner Multum)
• Atorvastatin Advanced Consumer Information (Micromedex)
• Atorvastatin Calcium AHFS DI Monographs (ASHP)